Denghai Zhang

1.7k total citations · 1 hit paper
37 papers, 1.4k citations indexed

About

Denghai Zhang is a scholar working on Complementary and alternative medicine, Molecular Biology and Oncology. According to data from OpenAlex, Denghai Zhang has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Complementary and alternative medicine, 19 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Denghai Zhang's work include Natural Compounds in Disease Treatment (19 papers), MicroRNA in disease regulation (4 papers) and Cell death mechanisms and regulation (4 papers). Denghai Zhang is often cited by papers focused on Natural Compounds in Disease Treatment (19 papers), MicroRNA in disease regulation (4 papers) and Cell death mechanisms and regulation (4 papers). Denghai Zhang collaborates with scholars based in China, France and United States. Denghai Zhang's co-authors include Xue Zhang, Bin Peng, Yuting Song, Georges Uzan, Bin Peng, Fanfan Cao, Xinghui Liu, Zhi‐Ru Ge, Hairong Wang and Shengqiong Deng and has published in prestigious journals such as PLoS ONE, Critical Care Medicine and Annals of Oncology.

In The Last Decade

Denghai Zhang

37 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

2020 359 citations Denghai Zhang, Xue Zhang et al. Journal of Integrative Medicine profile →

Peers

Countries citing papers authored by Denghai Zhang

Since Specialization

Citations

This map shows the geographic impact of Denghai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denghai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denghai Zhang more than expected).

Fields of papers citing papers by Denghai Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denghai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denghai Zhang. The network helps show where Denghai Zhang may publish in the future.

Co-authorship network of co-authors of Denghai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Denghai Zhang. A scholar is included among the top collaborators of Denghai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denghai Zhang. Denghai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of global research trends and prospects on celastrol, a principal bioactive ingredient of Tripterygium wilfordii Hook F: bibliometric analysis 2025 ·Pharmaceutical Biology ·(unknown), Yufang Wang, Xue Zhang, Lin Yang, (unknown), Denghai Zhang, (unknown)	2
2	Arginine tagged liposomal carrier for the delivery of celastrol for ferroptosis-induced hepatocellular carcinoma therapy 2025 ·Colloids and Surfaces B Biointerfaces ·(unknown), Kai Zhang, Xue Zhang, (unknown), (unknown), Chao Wang, (unknown), Denghai Zhang, Jian Zhang	1
3	Hyperglycemia exacerbates cerebral ischemia/reperfusion injury by up-regulating autophagy through p53-Sesn2-AMPK pathway 2024 ·Neuroscience Letters ·Rui Wang, Meng Wang, (unknown), Wenjun Wang, Denghai Zhang, P. Andy Li, Jianzhong Zhang, (unknown)	2
4	Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis 2024 ·Drug Design Development and Therapy ·(unknown), (unknown), (unknown), Denghai Zhang	4
5	Celastrol induces ferroptosis by suppressing RRM2 in hepatocellular carcinoma 2024 ·Heliyon ·Xue Zhang, (unknown), (unknown), (unknown), Jian Zhang, Yijun Tian, Denghai Zhang	6
6	Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells 2024 ·Journal of Integrative Medicine ·Jiajia Liu, (unknown), (unknown), (unknown), (unknown), Bin Peng, Denghai Zhang	9
7	Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway 2023 ·PLoS ONE ·(unknown), Meng Wang, Yanmei Ma, (unknown), Denghai Zhang, Fengying Guo, Li Jing, Jianzhong Zhang	7
8	Oxymatrine Alleviates Hyperglycemic Cerebral Ischemia/Reperfusion Injury via Protecting Microvessel 2022 ·Neurochemical Research ·Wenjun Wang, Yanmei Ma, (unknown), Denghai Zhang, Rui Wang, Jing Li, Jianzhong Zhang	10
9	Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization 2019 ·The International Journal of Biochemistry & Cell Biology ·Shengqiong Deng, (unknown), Zhi‐Ru Ge, Yuting Song, Hairong Wang, Xinghui Liu, Denghai Zhang	211
10	Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance 2018 ·Anti-Cancer Drugs ·Ying Wang, Qiuyun Liu, Haojie Chen, (unknown), Bin Peng, Fanfan Cao, Xue Zhang, Qing Chen, Georges Uzan, Limin Xu, Denghai Zhang	17
11	The level of soluble programmed death ligand-1 in lung cancer: An exploratory biomarker study 2016 ·Annals of Oncology ·Rui Geng, Li Pan, Shu Guo, (unknown), (unknown), (unknown), (unknown), Denghai Zhang, Xia Song	1
12	Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37 2016 ·FEBS Open Bio ·Bin Peng, (unknown), Ying Wang, (unknown), Xue Zhang, Denghai Zhang, Jian Hou	9
13	Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems 2015 ·Journal of Neuroimmune Pharmacology ·Ying Wang, Lu Cao, Limin Xu, Fanfan Cao, Bin Peng, Xue Zhang, (unknown), Georges Uzan, Denghai Zhang	34
14	Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol 2015 ·BMC Cancer ·Lu Cao, Xue Zhang, Fanfan Cao, Ying Wang, (unknown), (unknown), Georges Uzan, Bin Peng, Denghai Zhang	26
15	Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells 2014 ·BMC Cancer ·Bin Peng, Xue Zhang, Fanfan Cao, Ying Wang, Limin Xu, Lu Cao, (unknown), Maoquan Li, Georges Uzan, Denghai Zhang	3
16	U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues 2013 ·Oncology Letters ·Jinhui Hu, Hongxing Ye, Denghai Zhang, Weiwei Liu, Min Li, Ying Mao, Yuan Lu	15
17	Th17-relevant cytokines vary with sera of different ANA staining patterns 2013 ·International Immunopharmacology ·Jinhui Hu, Wei Meng, Denghai Zhang, (unknown), Hua Ling, (unknown), Xiaoxue He, Hongxing Ye	4
18	Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection 2012 ·Molecular Cancer ·Li Weng, Juan Du, Qing-Hui Zhou, Binbin Cheng, Jun Li, Denghai Zhang, Changquan Ling	79
19	Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice 2010 ·Critical Care Medicine ·Yanjie Wan, Jing Xu, (unknown), Yuhua Bao, (unknown), Niyati Lobo, Marcela P. Vizcaychipi, Denghai Zhang, Steve Gentleman, Mervyn Maze, Daqing Ma	136
20	Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus 2009 ·Arthritis Research & Therapy ·Juan Du, Min Li, Denghai Zhang, Xiaoyan Zhu, Weiwei Zhang, Wei Gu, (unknown), Xiaofeng Zhai, Changquan Ling	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact